Found "Public health policy": 1,044 results
Evaluating the Value of a Real-World HTA Agency
As countries develop their health systems on the path to Universal Health Coverage (UHC) (#LeaveNoOneBehind), many countries are experimenting with the development of a health technology assessment (HTA) agency in order to set priorities for health benefit packages, make go/no go decisions about
Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges
Generic reference cases for economic evaluation (EE) of “cure-based” health technologies may not fit into the new healthcare paradigm of precision medicine (PM). Current EE approaches were challenged by the complex evolving decision space of PM, lack of clinical evidence due to small patient cluster
Evaluating HITAP: 2 years on
\"First Step”, a program evaluation report, assessing HITAP’s two-year efforts and providing recommendations for further development of HITAP. This program evaluation was conducted by four external evaluators including Prof. John Cairns, Dr. Kalipso Chalkidou, Prof. Paibul Suriyawongpaisal, and Dr. Jirawat Panpiemras. Moreover, Prof. Mark Sculp
EU agency lifts lid on drug data secrets
(Reuters) – Europe’s medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information.The change is a landmark in transparency that puts E
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? (2013)
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
Thavorncharoensap M1, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P
1Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand ; Heal
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients in the Thai healthcare system
The Thai healthcare system faces pressure to fund high-cost new branded pharmaceuticals. Paying more may encourage innovation with positive implications for future population health, but it also means less money is available to fund other healthcare with negative implications for current population
Estimating the potential overdiagnosis and overtreatment of acute appendicitis in Thailand using a secondary data analysis of service utilization before, during and after the COVID-19 lockdown policy
Acute appendicitis is one of the most common surgical emergencies; however, optimal diagnosis and treatment of acute appendicitis remains challenging. We used the coronavirus disease 2019 (COVID-19) lockdown policy as a natural experiment to explore potential overdiagnosis and overtreatment of acute
Establishment of the Medical Technology Assessment Board (MTAB): Initiating Health Technology Assessment (HTA) in India
Since 2013, the HITAP International Unit (HIU) has been providing technical support to various developing countries such as Indonesia, Vietnam, Bhutan, and India by sharing the Thai experience in generating and using health technology assessment (HTA) to inform policy decisions. HITAP works in colla
Essential medicines for universal health coverage (2016)
Veronika J Wirtz*, Hans V Hogerzeil*, Andrew L Gray*, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt,
Sun Jing, Vera L Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian,
Dennis Ross-Degnan, Peter N Stephens,
eSanjeevani, the National Telemedicine service: Bridging healthcare gaps in India
– eSanjeevani was developed primarily to tackle the challenges of inequitable healthcare access and the shortage of healthcare professionals in India
– The ‘one application’ approach ensured that only one application is used for the national telemedicine service delivery, thus ensuring interoper
10 / Page